Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David E Gerber, M.D.
University of Texas Southwestern Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado Cancer Center, Anschutz Medical Campus
Denver, Colorado, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Knight Cancer Institute, Oregon Health and Science University
Portland, Oregon, United States
- University of Pittsburgh Medical Center Cancer Center
Pittsburgh, Pennsylvania, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- the University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2013
- Primary completion
- 30 Jun 2016
- Completion
- 30 Jun 2016
- Last update posted
- 13 Apr 2017
- Registered enrollment
- 55
- Registry id
- NCT01951690
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.